JAM-A as a prognostic factor and new therapeutic target in multiple myeloma.

about

Creating artificial lymphoid tissues to study immunity and hematological malignancies.JAM-A knockdown accelerates the proliferation and migration of human keratinocytes, and improves wound healing in rats via FAK/Erk signaling

P2860

Q39252350-519D12E7-DE21-44B3-8323-9F80BFD9ACBA Q58699535-371D6AE3-F5FD-45F7-83C0-E921CE1B7118

P2860

JAM-A as a prognostic factor and new therapeutic target in multiple myeloma.

Item

http://www.wikidata.org/entity/Q47610951

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

JAM-A as a prognostic factor and new therapeutic target in multiple myeloma.

@en

JAM-A as a prognostic factor and new therapeutic target in multiple myeloma.

@nl

type

Item

label

JAM-A as a prognostic factor and new therapeutic target in multiple myeloma.

@en

JAM-A as a prognostic factor and new therapeutic target in multiple myeloma.

@nl

prefLabel

JAM-A as a prognostic factor and new therapeutic target in multiple myeloma.

@en

JAM-A as a prognostic factor and new therapeutic target in multiple myeloma.

@nl

P1476

JAM-A as a prognostic factor and new therapeutic target in multiple myeloma.

@en

P2093

A Beilhack

http://www.w3.org/2001/XMLSchema#string

A Brandl

http://www.w3.org/2001/XMLSchema#string

A Rosenwald

http://www.w3.org/2001/XMLSchema#string

A Ruckdeschel

http://www.w3.org/2001/XMLSchema#string

A Vacca

http://www.w3.org/2001/XMLSchema#string

C Graf

http://www.w3.org/2001/XMLSchema#string

F Jakob

http://www.w3.org/2001/XMLSchema#string

H Einsele

http://www.w3.org/2001/XMLSchema#string

J Dotterweich

http://www.w3.org/2001/XMLSchema#string

K Mattenheimer

http://www.w3.org/2001/XMLSchema#string

P2860

Cutting edge: combined treatment of TNF-alpha and IFN-gamma causes redistribution of junctional adhesion molecule in human endothelial cells

Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration

Paradigms lost-an emerging role for over-expression of tight junction adhesion proteins in cancer pathogenesis

Tension on JAM-A activates RhoA via GEF-H1 and p115 RhoGEF.

The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression.

Dysregulation of JAM-A plays an important role in human tumor progression

Non-invasive imaging provides spatiotemporal information on disease progression and response to therapy in a murine model of multiple myeloma.

Jam1a-Jam2a interactions regulate haematopoietic stem cell fate through Notch signalling.

Overexpression of JAM-A in non-small cell lung cancer correlates with tumor progression

In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.

P2888

leu.2017.287

P304

736-743

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LEU.2017.287

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Regina Ebert

Antonio Giovanni Solimando

P577

2017-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1092350954

http://www.w3.org/2001/XMLSchema#string

P698

29064484

http://www.w3.org/2001/XMLSchema#string

P932

5843918

http://www.w3.org/2001/XMLSchema#string

JAM-A as a prognostic factor and new therapeutic target in multiple myeloma.

about

P2860

P2860

JAM-A as a prognostic factor and new therapeutic target in multiple myeloma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932